Related Experiment Video
Updated: May 3, 2026

05:18
Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
232
Implantable left ventricular assist devices and the kidney
Huijuan Mao1, Nevin Katz, Jeong Chul Kim
1Department of Nephrology, Ospedale San Bortolo, Vicenza, Italy.
Blood Purification
|February 15, 2014
Summary
Left ventricular assist devices (LVADs) improve heart failure by restoring cardiac output. This review examines LVADs
Area of Science:
- Cardiology
- Nephrology
- Medical Devices
Background:
- Advanced heart failure often involves pre-existing renal dysfunction.
- Left ventricular assist devices (LVADs) improve systemic perfusion but their impact on renal function is complex.
- Contradictory findings exist regarding renal function changes after LVAD implantation.
Purpose of the Study:
- To review current knowledge on LVADs' effects on renal hemodynamics, physiology, and pathology.
- To clarify the impact of LVADs on renal function before and after implantation.
- To guide patient selection and refine LVAD therapy for optimal renal outcomes.
Main Methods:
- Literature review of studies investigating LVADs and renal function.
- Analysis of hemodynamic, physiological, and pathological data related to LVAD support.
- Synthesis of clinical outcomes and risk factors associated with renal function post-LVAD.
Main Results:
- LVADs can improve renal perfusion by restoring cardiac output.
- Renal function changes post-LVAD are variable and influenced by pre-existing conditions.
- Understanding these dynamics is crucial for managing patients with heart failure and renal compromise.
Conclusions:
- LVADs offer significant benefits for advanced heart failure patients.
- Further research is needed to fully elucidate renal pathophysiology during LVAD support.
- Optimizing LVAD therapy requires careful consideration of individual patient renal status.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Heart Failure VI: Adjunct Therapies
632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Kidney Transplant I: Introduction
827
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
827
Kidney Transplant II: Surgical Procedure
926
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
926
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.9K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790

